Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, settembre 17
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Core Laboratories Inc
CLB
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$11.40
-0.05
-0.44%
In chiusura: Sep 17, 5:00 PM EST
$11.40
N/A
Post-mercato: 4:00 PM EST
Get Report
Panoramica
Notizie
Previsioni utili
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Core Laboratories Financials
Core Laboratories (CLB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Top 3 Energy Stocks You'll Regret Missing In September
Oversold energy stocks may offer buying opportunities, with Baker Hughes, CNX Resources and Core Laboratories showing RSI readings below 30.
Avi Kapoor
PRO
Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 42.11 percent decrease over earnings of $0.19 per share from the
Benzinga Newsdesk
PRO
Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.330M Est
Core Laboratories (NYSE:CLB) is looking for Q3 GAAP EPS of $0.12-$0.20 vs $0.16 analyst estimate. sees sales of $128.500 million-$135.500 million vs $131.330 million analyst estimate.
Benzinga Newsdesk
PRO
Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.900M Est
Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.06-$0.12 vs $0.09 analyst estimate. sees sales of $123.000 million-$131.000 million vs $127.900 million analyst estimate.
Benzinga Newsdesk
PRO
Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.11 by 45.45 percent. This is a 57.14 percent decrease over earnings of $0.14 per share from
Benzinga Newsdesk
Earnings Scheduled For April 29, 2026
Benzinga Insights
Privacy Manager